bosentan anhydrous has been researched along with Bronchopulmonary Dysplasia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steinhorn, RH | 1 |
| Birk, E; Bruckheimer, E; Dagan, T; Kadmon, G; Schiller, O; Schonfeld, T | 1 |
| Gewitz, M; Krishnan, S; Krishnan, U | 1 |
| Beghini, R; Errico, G; Ilic, S; Padovani, EM; Richelli, C; Rugolotto, S | 1 |
4 other study(ies) available for bosentan anhydrous and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Diagnosis and treatment of pulmonary hypertension in infancy.
Topics: Bosentan; Bronchopulmonary Dysplasia; Hernia, Diaphragmatic; Humans; Hypertension, Pulmonary; Infant, Newborn; Milrinone; Nitric Oxide; Piperazines; Prostaglandins; Purines; Signal Transduction; Sildenafil Citrate; Sulfonamides; Sulfones; Vascular Resistance | 2013 |
Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia.
Topics: Antihypertensive Agents; Bosentan; Bronchopulmonary Dysplasia; Child, Preschool; Drug Therapy, Combination; Echocardiography; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Male; Retrospective Studies; Sildenafil Citrate; Sulfonamides; Treatment Outcome | 2017 |
Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.
Topics: Administration, Oral; Antihypertensive Agents; Bosentan; Bronchopulmonary Dysplasia; Cardiac Catheterization; Child; Child, Preschool; Chronic Disease; Female; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Male; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2008 |
Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia.
Topics: Antihypertensive Agents; Bosentan; Bronchopulmonary Dysplasia; Drug Therapy, Combination; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Severity of Illness Index; Sulfonamides | 2006 |